Sign in Subscribe
Universities and colleges

Tumor Suppressor p53: A Low Threshold for Cancer Inactivation

Strategic Insights

— 1 min read

A recent study from Hokkaido University's Department of Chemistry, led by R. Kamada, has shed light on the critical role of tetramerization domain mutants in the inactivation of the tumor suppressor p53. The research reveals that a small destabilization of the tetrameric structure of p53 can result in a significant loss of tumor suppressor activity, suggesting that the threshold for inactivation is extremely low. This finding has significant implications for cancer research and treatment.

Key Takeaways:

  • The tumor suppressor p53 is a 393-amino acid transcription factor that induces cell cycle arrest and apoptosis in response to genotoxic stress.
  • About 50% of human tumors have TP53 gene mutations, with most being missense mutations that lower the tumor suppressor activity of p53.
  • The tetramerization domain of p53 is critical for its post-translational modification and ability to activate or repress the transcription of target genes.
  • The stability of mutant peptides representing 49 known tumor-derived missense substitutions in humans varied widely, from -46.8°C to 4.8°C.
  • The destabilization of the tetrameric structure of p53 can lead to dysfunction of tumor suppressor activity, with a low threshold for inactivation.
  • The tetramerization domain's electrostatic surface potential and ability to bind partner proteins may also be important for its function.
  • R. Kamada, a researcher from Hokkaido University's Department of Chemistry, conducted the study with colleagues.
  • The research was published in the Journal of Biological Chemistry in 2011.
  • Gene Therapy Weekly editors prepared the article from staff and other reports.
  • The study was supported by the Department of Chemistry, Faculty of Science, Hokkaido University.

Statistics:

  • 393: the number of amino acids in p53
  • 50%: the percentage of human tumors with TP53 gene mutations
  • -46.8°C to 4.8°C: the range of stability of mutant peptides representing 49 tumor-derived missense substitutions
  • 49: the number of missense mutations analyzed in the study
  • Journal of Biological Chemistry: the publication where the study was published
  • 2011: the year the study was published

Sources:

  • Journal of Biological Chemistry
  • Cancer Gene Therapy

Read more